Ecto-5'-nucleotidase in B-cell chronic lymphocytic leukemia.

Literature on the behaviour of ecto-5'-nucleotidase in the course of B-cell chronic lymphocytic leukemia is briefly reviewed and aims for further researches are highlighted.

[1]  S. Colgan,et al.  Regulation of Endothelial CD73 by Adenosine: Paracrine Pathway for Enhanced Endothelial Barrier Function1 , 2000, The Journal of Immunology.

[2]  A Rzhetsky,et al.  Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions. , 2000, Current topics in microbiology and immunology.

[3]  H Zimmermann,et al.  5'-Nucleotidase: molecular structure and functional aspects. , 1992, The Biochemical journal.

[4]  A. Ho,et al.  Purine degradative enzymes in circulating malignant cells of patients with chronic B cell neoplasia , 1987, Hematological oncology.

[5]  Y. Hey,et al.  Assignment of ecto-5′-nucleotidase to human chromosome 6 , 1988, Human Genetics.

[6]  A. Lucas,et al.  Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73). , 1990, Tissue antigens.

[7]  G. Pangalis,et al.  Patterns of adenosine deaminase, ecto-5′-nucleotidase, poly(A)polymerase and surface light chain expression in chronic lymphocytic leukemias , 1989, Blut.

[8]  A. Chalmers,et al.  Lymphocyte 5′-ectonucleotidase: an indicator of oxidative stress in humans? , 2000, Redox report : communications in free radical research.

[9]  E. Montserrat,et al.  "Smouldering" Chronic Lymphocytic Leukemia. , 1991, Leukemia & lymphoma.

[10]  B. Mitchell,et al.  Tissue-specific Regulation of the Ecto-5′-nucleotidase Promoter , 1999, The Journal of Biological Chemistry.

[11]  S. Molica,et al.  What is changing in the natural history of chronic lymphocytic leukemia? , 2001, Haematologica.

[12]  L. Thompson,et al.  Ecto‐enzyme and signaling functions of lymphocyte CD 7 3 , 1998, Immunological reviews.

[13]  Mark J. Thomas,et al.  A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis , 1981, Cancer.

[14]  K. Rajewsky,et al.  CD5‐positive B cells in healthy elderly humans are a polyclonal B cell population , 2000, European journal of immunology.

[15]  U. Dianzani,et al.  Co-stimulatory signal delivered by CD73 molecule to human CD45RAhiCD45ROlo (naive) CD8+ T lymphocytes. , 1993, Journal of immunology.

[16]  L. Thompson.  5'-nucleotidase--an overview of the last three years. , 1991, Advances in Experimental Medicine and Biology.

[17]  E. Ascari,et al.  5′ nucleotidase in chronic b cell leukemias: A cytochemical and ultrastructural study , 1990, American journal of hematology.

[18]  F. Sharom,et al.  Release of the glycosylphosphatidylinositol-anchored enzyme ecto-5'-nucleotidase by phospholipase C: catalytic activation and modulation by the lipid bilayer. , 1998, The Biochemical journal.

[19]  Wyeth Wasserman,et al.  Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[20]  K. Klotz.  Adenosine receptors and their ligands , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[21]  S. Jalkanen,et al.  Differential Regulation and Function of CD73, a Glycosyl-Phosphatidylinositol–linked 70-kD Adhesion Molecule, on Lymphocytes and Endothelial Cells , 1997, The Journal of cell biology.

[22]  L. Thompson,et al.  T cell signalling through CD73. , 1997, Cellular signalling.

[23]  C. Webb,et al.  Isolation and characterization of the promoter of the human 5'-nucleotidase (CD73)-encoding gene. , 1995, Gene.

[24]  E. Cronkite,et al.  Clinical staging of chronic lymphocytic leukemia. , 1975, Blood.

[25]  G. Dighiero,et al.  The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. , 1994, Immunology today.

[26]  E. Thiel,et al.  Prognostic implication of Ecto‐5′‐nucleotidase activity in acute lymphoblastic leukemia , 1990, Cancer.

[27]  S. Jalkanen,et al.  CD73 Engagement Promotes Lymphocyte Binding to Endothelial Cells Via a Lymphocyte Function-Associated Antigen-1-Dependent Mechanism1 , 2000, The Journal of Immunology.

[28]  L. Thompson,et al.  Purification of 5'-nucleotidase from human placenta after release from plasma membranes by phosphatidylinositol-specific phospholipase C. , 1987, Biochemical and biophysical research communications.

[29]  P. Galieni,et al.  5'-nucleotidase activity in lymphocytes from patients affected by B-cell chronic lymphocytic leukemia. , 1998, Clinical biochemistry.